BioWorld

Nov. 17, 2008

Resisting Bug Resistance With New and Better Antibiotics

The emergence of antibiotic resistance has put pressure on scientists working to replace the increasingly ineffective therapies, while a potential epidemic threat moves to the forefront of their minds. Read More

Money Raised Year to Date

Stock Winners and Losers For The Week

Phase I Clinical Trials Update: October 2008

Phase II Clinical Trials Update: October 2008

Pivotal/Phase III Clinical Trials Update: October 2008

American College of Rheumatology Annual Meeting

Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and Infectious Diseases Society of America

Non-U.S. Clinical Trials And Regulatory Actions: October 2008

FDA Submissions, Approvals And Other Actions: October 2008

BioWorld Stock Report For Public Biotechnology Companies

Today's news in brief

BioWorld

BioWorld briefs for Jan 16, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 16, 2026.

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...

Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

BioWorld

With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...